BCR and TLR Signaling Pathways Are Recurrently Targeted by Genetic Changes in Splenic Marginal Zone Lymphomas

Haematologica - Italy
doi 10.3324/haematol.2011.054080
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Splenic Marginal Zone Lymphoma

2020English

Splenic Marginal Zone Lymphomas Appear to Originate From Different B Cell Types

American Journal of Pathology
Forensic MedicinePathology
2002English

CD79B and MYD88 Mutations in Splenic Marginal Zone Lymphoma

ISRN Oncology
2013English

The Multiple Faces of Marginal Zone Lymphomas

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

A Case of Splenic Marginal Zone Lymphoma

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2008English

Recurrent Autoimmune Hemolytic Anemia in Splenic Marginal Zone Lymphoma

Journal of Community Hospital Internal Medicine Perspectives
Internal Medicine
2018English

Primary Splenic Marginal Zone Lymphoma: A Case Report

Pathology
Forensic MedicinePathology
2016English

Idelalisib and Rituximab in 17p Deletion–Positive Splenic Marginal Zone Lymphoma

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2018English

Regulation of TLR Signaling Pathways by microRNAs: Implications in Inflammatory Diseases

Central-European Journal of Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy